Compare Farmacias Benavides SAB de CV with Similar Stocks
Dashboard
1
With ROE of 52.73%, it has a very expensive valuation with a 10.39 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of NA, its profits have risen by 194% ; the PEG ratio of the company is 0.1
2
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.7%
0%
8.7%
6 Months
25.0%
0%
25.0%
1 Year
32.28%
0%
32.28%
2 Years
180.9%
0%
180.9%
3 Years
177.16%
0%
177.16%
4 Years
78.57%
0%
78.57%
5 Years
47.06%
0%
47.06%
Farmacias Benavides SAB de CV for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.40%
EBIT Growth (5y)
42.16%
EBIT to Interest (avg)
2.03
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
13.69
Tax Ratio
36.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
201.24%
ROE (avg)
42.53%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
10.39
EV to EBIT
8.10
EV to EBITDA
4.11
EV to Capital Employed
9.48
EV to Sales
0.44
PEG Ratio
0.10
Dividend Yield
NA
ROCE (Latest)
117.09%
ROE (Latest)
52.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bearish
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
5,539.70
4,642.20
19.33%
Operating Profit (PBDIT) excl Other Income
630.90
496.80
26.99%
Interest
145.50
124.50
16.87%
Exceptional Items
0.00
0.00
Consolidate Net Profit
190.30
98.60
93.00%
Operating Profit Margin (Excl OI)
58.90%
51.20%
0.77%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 19.33% vs 5.91% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 93.00% vs 46.51% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
19,458.50
17,646.50
10.27%
Operating Profit (PBDIT) excl Other Income
2,098.50
1,908.60
9.95%
Interest
469.00
506.20
-7.35%
Exceptional Items
0.00
0.00
Consolidate Net Profit
224.10
130.50
71.72%
Operating Profit Margin (Excl OI)
48.90%
48.00%
0.09%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 10.27% vs 2.44% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 71.72% vs -53.77% in Dec 2024
About Farmacias Benavides SAB de CV 
Farmacias Benavides SAB de CV
Retailing
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
Company Coordinates 
Company Details
Avenida Fundadores No. 935 interior 301, Col. Valle del Mirador MONTERREY None : 64750
Registrar Details






